| Summary of Significant Accounting Policies | Note 2 – Summary of Significant Accounting
Policies Accounting Principles The accompanying unaudited consolidated financial
statements have been prepared by management using the accrual basis of accounting in accordance with accounting principles generally
accepted in the United States of America (“U.S. GAAP”) for interim financial statements and with the instructions to Article
10 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all of
the information and footnotes required by U.S. GAAP for annual financial statements. In the opinion of the Company’s management,
the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring
accruals) to present the financial position of the Company at November 30, 2024, and the results of operations and cash flows for the
periods presented. The results of operations for the six months ended November 30, 2024, are not necessarily indicative of the operating
results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction
with the audited financial statements and related notes thereto for the year ended May 31, 2024. Use of Estimates The preparation of financial statements in conformity
with U.S. GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and
expenses during the reporting periods. Making estimates requires management to exercise significant judgment. Certain of these estimates
could be affected by external conditions, including those unique to the Company’s businesses, and general economic conditions.
These external conditions could have an effect on the Company’s estimates that could cause actual results to differ materially
from its estimates. Actual results could differ from those estimates. The Company re-evaluates all of its accounting estimates at least
quarterly based on these conditions and records adjustments when necessary. Significant estimates relied upon in preparing these statements
include revenue recognition, accounts receivable reserves, accrued expenses, share-based compensation and the recoverability of the Company’s
net deferred tax assets and any related valuation allowance. Principles of Consolidation The consolidated financial statements include
the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Cash and Cash Equivalents Cash equivalents are short-term, highly liquid
investments that are readily convertible to cash with original maturities of three months or less at the date acquired. The Company had
zero Accounts Receivable Included in accounts receivable on the balance
sheets are amounts primarily related to customers. The Company estimates losses on receivables based on known troubled accounts and historical
experience of losses incurred. Receivables are considered impaired and written off when it is probable that all contractual payments
due will not be collected in accordance with the terms of the related agreement. Based on experience and the judgment of management,
there was no Revenue Recognition The Company follows the Financial Accounting
Standards Board’s (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with
Customers (Topic 606), Under ASU No. 2014-09, the Company recognizes
revenue when a customer obtains control of promised goods or services, or when they are shipped to a customer, in an amount that reflects
the consideration that it expects to receive in exchange for them. The Company recognizes revenues following the five-step model prescribed
under ASU No. 2014-09: (a) it identifies a contract with a customer; (b) it identifies the performance obligations in the contract;
(c) it determines the transaction price; (d) it allocates the transaction price to the performance obligations in the contract; and (e)
it recognizes revenues when (or as) it satisfies its performance obligation. The Company generates revenue from multiple streams,
namely, clinical trials, consulting fees, seminars and merchandise sales. Revenues from product sales are recognized when a customer
obtains control of the Company’s product, which occurs at a point in time or over time, typically upon shipment to the customer
or when services are fulfilled and the customer receives benefit from such services. Revenue is deferred and a liability is established
to the extent that the Company receives payments from customers in advance of goods being shipped or services being rendered. The Company expenses incremental costs of obtaining
a contract as and when incurred if the expected amortization period of the asset in which it would have been recognized is one year or
less or the amount is immaterial. A performance obligation is a contractual promise
to transfer a distinct product or service to a customer and is the unit of account in the new revenue standard. The contract transaction
price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.
Each contract has a single performance obligation as the promise to transfer the individual goods or services is not separately identifiable
from other promises in the contracts and, therefore, not distinct. Revenue from contracts that satisfy the criteria for overtime recognition
is recognized as the work progresses. The majority of the Company’s revenue is derived from services provided to customers and
is executed typically over a period that is typically between 1 to 12 months, based on evaluation of when these services are rendered.
Contracts will continue to be recognized over time because of the continuous transfer of control to the customer as services are rendered
to customers. Payments made by customers in advance of services being rendered are recorded as deferred revenue. Our significant payment terms for customer contracts
vary based on the revenue stream. Franchising business clients are required to advance a percentage of the franchise fee upon acceptance
of the contract. These advances, when received, are accounted for as contract liabilities on the consolidated balance sheet and are subsequently
recognized in revenue when they are earned. Contracts for clinical trials typically provide for progress payments based on the number
of patients seen, with final payments generally due within 30 days upon completion of work or the termination of the contract. Revenue
is recognized when all performance obligations under the terms of a contract are satisfied. The Company requires advance payments from
its consulting customers and these payments are recorded as contract liabilities on the consolidated balance sheet until service is performed
and revenue is recognized. These advance payments are not treated as financing component based on the guidance in ASC 606-10-32-196-16
and -17, whereby the timing of when services are provided are at the discretion of the customers or a substantial amount of the consideration
promised by the customer is variable and not in the control of the customer or the Company. There is no significant financing component
to any of the Company’s contracts. Contracts for educational services require nonrefundable
payment in advance and are recorded as revenue when received. There is no significant financing component to
any contracts. Contract Modifications Contracts for the Company’s clinical trial
business are subject to modification. These modifications may create new, or change existing, enforceable rights and obligations of the
parties thereto. Modifications are generally effected pursuant to an amendment or addendum to the original contract. A contract modification
is accounted for as a new contract if it reflects an increase in scope that is regarded as distinct from the original contract and is
priced in line with the standalone price for the related services. If a contract modification is not considered a new contract, the modification
is combined with the original contract and the impact on revenue recognition will depend on whether the remaining services are distinct
from the original contract. If they are distinct from those in the original contract, all remaining performance obligations will be accounted
for on a prospective basis, with unrecognized consideration allocated to the remaining performance obligations. If the remaining goods
or services are not distinct, the modification will be treated as if it were a part of the existing contract and the effect that the
contract modification has on the transaction price and the measure of progress toward satisfaction of the performance obligations are
recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) at the date of the contract modification
on a cumulative catch-up basis. Remaining Performance Obligations The Company follows ASC 606, which requires the
allocation of the transaction price to the remaining performance obligations of a contract and applies a practical expedient allowing
it not to disclose the amount of the transaction price allocated to the remaining performance obligations for contracts with an original
expected duration of one year or less. At November 30, 2024, and May 31, 2024, the Company had no Share-Based Payments ASC 718, “ Compensation – Stock
Compensation, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting,
Equity – Equity-Based Payments to Non-Employees. Leases The Company has adopted ASU 2016-02, Leases
(Topic 842), Cash Flows The Company follows ASU 2016-18, “ Statement
of Cash Flows (Topic 230), Fair Value Measurements The Company has adopted ASC Topic 820, Fair
Value Measurements, The estimated fair value of certain financial
instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, is carried at historical
cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of the Company’s
short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual
interest rates taken together with other features, such as concurrent issuances of warrants and/or embedded conversion options, are comparable
to rates of returns for instruments of similar credit risk. ASC Topic 820 defines fair value as the exchange
price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market
for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 also establishes
a fair-value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs
when measuring fair value. ASC Topic 820 describes three levels of inputs that may be used to measure fair value: Level 1: Quoted prices in active markets for identical
assets or liabilities. Level 2: Quoted prices for similar assets and liabilities
in active markets or inputs that are observable. Level 3: Inputs that are unobservable (for example, cash
flow modeling inputs based on assumptions). Income Taxes The Company accounts for income taxes in accordance
with Accounting Standards Codification No. 740, “Income Taxes” Deferred tax liabilities and assets are classified
as current or noncurrent based on the classification of the related asset or liability for financial reporting or according to the expected
reversal dates of the specific temporary differences, if not related to an asset or liability for financial reporting. The Company accounts for uncertain tax positions
in accordance with the provisions of ASC 740, which provides guidance as to the determination of whether tax benefits claimed or expected
to be claimed on a tax return should be recorded in its financial statements, under which a company may recognize the tax benefit from
an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. The tax benefits recognized in financial statements
from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate
settlement. Accordingly, the Company would report a liability for unrecognized tax benefits resulting from uncertain tax positions taken
or expected to be taken in a tax return. The Company elects to recognize any interest and penalties, if any, related to unrecognized
tax benefits in tax expense. Loss per Share The Company computes basic earnings per share
amounts in accordance with Accounting Standards Codification Topic 260, “Earnings per Share.” no Recently Issued Accounting Standards The Company does not believe there are any other
recently issued, but not yet effective, accounting standards that would have a significant impact on the Company’s financial position
or results of operations. |
